PREDICTOM is inviting general practitioners to take part in our survey. With the aim of identifying current clinical guidelines and practice for screening, identifying and diagnosing Alzheimer's Disease and early dementia, we want to hear your views.
Photo: Svein Lunde, Helse Stavanger
Published 10 February 2025
Share this article
We are inviting general practitioners to complete this short survey. It should take around 10 minutes to complete. We want to hear about your current clinical practice when managing patients who you suspect have dementia. We also ask some questions about Alzheimer’s disease and mild cognitive impairment.
Your responses will help us develop recommendations for optimising clinical practice guidelines, considering new technologies to support diagnosis and facilitators and barriers to implementation in primary care settings.
What if Alzheimer's disease could be detected years before symptoms appear? In a newly launched nine-part video series "Predicting Dementia Before It Starts", experts from across PREDICTOM explore how advances in biomarkers, artificial intelligence, brain imaging and digital technologies, and patient involvement could enable earlier and more accurate detection of Alzheimer's disease.
PREDICTOM applies a risk enrichment strategy to support scalable early detection of Alzheimer’s disease while ensuring that healthcare resources are deployed where they add most value. Movement from Level 1 to Level 2 is based on predictive risk modelling using routine primary care data, enabling population wide reach combined with targeted depth.
Imagine checking your brain health the way you check your blood pressure or sleep patterns—quickly, privately, and from the comfort of your own home. That vision is no longer futuristic speculation but the driving force behind PREDICTOM, a major European study that is quietly reshaping how Alzheimer’s disease might be detected long before symptoms appear.
